Biocryst Pharmaceuticals Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biocryst Pharmaceuticals Inc with three other
companies in this sector in the United States:
Twist Bioscience Corp
sales of $25.43 million
of which 71%
was Synthetic genes),
Champions Oncology Inc
Adma Biologics Inc
of which 59%
was Plasma Collection Center).
Biocryst Pharmaceuticals Inc reported sales of $20.65 million
December of 2018.
decrease of 18.0%
versus 2017, when the company's sales were $25.19 million.